ANNUAL REPORT 2009-2010 - University of Toronto Department of ...
ANNUAL REPORT 2009-2010 - University of Toronto Department of ...
ANNUAL REPORT 2009-2010 - University of Toronto Department of ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>ANNUAL</strong> <strong>REPORT</strong> <strong>2009</strong>-<strong>2010</strong><br />
Rogers I (PI). Stem cell therapy for type 1 Diabetes. MaRS Innovations, $68,000, <strong>2009</strong> – <strong>2010</strong>.<br />
Rogers IM (PI). Treatment <strong>of</strong> peripheral vascular disease with stem cells. Stem Cell Network<br />
Impact Grant, $75,000, <strong>2009</strong> – <strong>2010</strong>.<br />
Rogers IM (PI). Comparison <strong>of</strong> CD34+ cells versus CD34+ cultured cells in the treatment <strong>of</strong><br />
PVD. MaRS – Pro<strong>of</strong> <strong>of</strong> Principle. $50,000, <strong>2010</strong> – 2011.<br />
Rogers IM (PI). Treatment <strong>of</strong> type 1 diabetes with stem cells. CIHR – Pro<strong>of</strong> <strong>of</strong> Principle,<br />
$150,000, <strong>2010</strong> – 2011.<br />
Rosen B. Canadian synoptic reporting in Canada. Canadian Partners against Cancer, $243,000<br />
per annum, 2008 – <strong>2010</strong>.<br />
Rossant J. Lineage development in the mouse blastocyst. CIHR, Operating Grant, $1,012,210,<br />
<strong>2009</strong> – 2014.<br />
Rossant J (Principal Investigator). Transcriptional networks in trophoblast stem cell<br />
development. CIHR, Operating Grant, $1,049,389, <strong>2010</strong> – 2015.<br />
Rossant J (PI), Adamson SL, Aubin JE, Cordes SP, Osborne LR, Quaggin SE, Roder JC,<br />
Stanford WL, Vallis KA, Van Der Kooy DJ, Vidal SM (Co-Investigators), Centre for Modeling<br />
Human Disease. Canadian Institutes <strong>of</strong> Health Research, Group Program, $2,532,330 ($506,466<br />
per annum + $15,000 Equipment), 2004 – <strong>2009</strong>.<br />
Sellers T (PI), Narod S (Co-Applicant). Haplotype-based genome screen for ovarian cancer loci.<br />
NIH/NCI, Grant #: R01 CA114343-01 A2, $50,000 US, March 2007 – February <strong>2010</strong>.<br />
Serghides L (PI), Loutfy MR, Murphy KE, Yudin MH. Angiogenesis and adverse pregnancy<br />
outcomes in women with HIV, a pilot study. CIHR, $95,710, March 1, <strong>2010</strong> – February 28 2011.<br />
Sermer M (Collaborator). Thrombophilia in Pregnancy Prophylaxis Study. Heart and Stroke<br />
Foundation <strong>of</strong> Canada, $24,000 per annum, 2006 – 2011.<br />
Sermer M (Co-Investigator). Longitudinal association <strong>of</strong> adipocytokines and markers <strong>of</strong> subclinical<br />
inflammation with changes in insulin resistance and beta-cell function in women with a<br />
history <strong>of</strong> gestational diabetes mellitus. Canadian Institutes <strong>of</strong> Health Research, $148,969 per<br />
annum, 2007 – 2012.<br />
Sermer M (CI). The Canadian Healthy Infant Longitudinal Development (CHILD) Study.<br />
CIHR, $347,549 per annum, 2007 – 2016.<br />
Sermer M (Co-Investigator). The impact <strong>of</strong> dietary factors on the pathophysiology <strong>of</strong> gestational<br />
diabetes and subsequent type 2 diabetes. Canadian Diabetes Association, $90,863 per annum,<br />
2008 – 2011.<br />
Sermer M (PI). Food Frequency Questionnaire Validation Study – MIREC. <strong>Toronto</strong> Health<br />
Canada, $9,999 per annum, <strong>2009</strong> – 2011.<br />
130
Change language